'Pretty striking': Pfizer results prompt calls for Australian investment in new technology

  • 📰 theage
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 77%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Strong early results from Pfizer and BioNTech's phase 3 coronavirus vaccine trial have been welcomed by local vaccine experts, promoting renewed calls for Australia to invest in new types of vaccine manufacturing technology.

She warned there were still key unknowns about the results, however, including how long the protection against the virus might last and whether some cohorts of trial participants may not be seeing benefits from the vaccine.

The Pfizer product, known as BNT162b2, has already been granted a provisional determination by Australia's Therapeutic Goods Administration, which paves the way for Pfizer to apply for a provisional registration of the product.and began this process on Monday. CSL will also make the University of Queensland's vaccine if it passes trials.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

no data released. so whatever happened to peer review? what kind of scientists promote this before seeing ANY data? no wonder people have trust issues... 'With Pfizer's release on Monday, however, Haseltine said there wasn't any data in the release.'

They said there will be 1.2B vaccines produced by the end of 2021. So only 650M will get it. There are 7B people in the world. It's going to be a long time before we all can, if we want to, get a vaccine shot.

Timed after the election in order to deprive Trump of an advantage.

Roll up, roll up sheep. Have your DNA irreversibly altered by this poisonous concoction which has ZERO documentation in regards to long-term health effects. You only have a 99.97% chance of surviving the deadly Rona, so just be a good bootlicker and take the jab. You'll be fine.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 8. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인